Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks callers offered up during the "Mad Money Lightning Round" Monday evening:
Avanir Pharmaceuticals (AVNR): "This is a great speculative biotech. We will need to take profits at years' end, but for now, they're OK."
Fortress Investments (FIG - Get Report): "I'm thinking that this is a decent buy."
Must Read: 'Mad Money' Lightning Round: Stay Out of Exxon
HCI Group (HCI - Get Report): "I like the homeowners' insurers. I think they're inexpensive on their book value."
Primerica (PRI - Get Report): "This is a great long-term play and a good company."
DaVita (DVA - Get Report): "I'm worried about DaVita. They have some reimbursement issues. I'd like to get clarification on what the problems are. "
Nuverra Environmental Solutions (NES - Get Report): "We need to see more natural gas drilling for this one to do well. That's why this stock has been a disappointment so far."
Raptor Pharmaceuticals (RPTP - Get Report): "This is an early-stage biotech. Take some profits."
To read a full recap of "Mad Money" on CNBC, click here.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
-- Written by Scott Rutt in Washington, D.C.
To email Scott about this article, click here: Scott Rutt
Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC